Novo Nordisk’s Wegovy made a significant impact on the obesity market when it launched in 2021.
Tirzepatide outpacing Wegovy in the obesity space
January 2, 2025
You may also like
Indices by TradingView
Categories
Indices by TradingView
Novo Nordisk’s Wegovy made a significant impact on the obesity market when it launched in 2021.